Compugen Reports First Quarter 2020 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Compugen Reports First Quarter 2020 Results

Compugen (CGEN) Reports In-Line Q1 EPS

May 6, 2020 7:20 AM EDT

Compugen (NASDAQ: CGEN) reported Q1 EPS of ($0.10), in-line with the analyst estimate of ($0.10).

"We have entered 2020 well positioned and with significant momentum to advance our clinical programs that address novel, internally-discovered, drug targets for cancer immunotherapy," said Anat Cohen-Dayag, Ph.D., President and CEO of Compugen. "On the clinical front, we recently presented at AACR updated data from our ongoing Phase 1 dose escalation study of COM701 as a monotherapy and in combination with Opdivo®. These encouraging data, which include... More